Stay connected and stay informed. Explore our news articles on all things ILD.
After the success of our first ILD-IN Webinar in September, please join us for Webinar 2. The webinar will be taking place on 10th December @
The ILD-IN is seeking applications from ILD-IN members to join the ILD-IN Committee. The Committee is a diverse mix of healthcare professionals from varying backgrounds
The long awaited guidance on the use of Nintedanib to treat IPF has been published by NICE. Nintedanib for treating idiopathic pulmonary fibrosis NICE technology